Abstract

Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products

Author(s): Wagner James T

Issue: Jul/Aug 2005 - Human Hormone Replacement Therapy

Page(s): 284-290

Download in electronic PDF format for $75
  • Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products Page 1
  • Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products Page 2
  • Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products Page 3
  • Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products Page 4
  • Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products Page 5
  • Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products Page 6
  • Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products Page 7

Abstract

The introduction of United States Pharmacopeia (USP) Chapter <797> and the National Institute for Occupational Safety and Health (NIOSH) alert for preventing occupational exposure to hazardous drugs have renewed interest in engineering controls used for compounding sterile drugs. Engineering controls are engineered equipment or machinery that eliminate or reduce the potential exposure of a preparation or personnel to contamination or a hazard. Primary engineering controls are employed directly at the point of use. Examples of primary engineering controls used in aseptic compounding are laminar airflow workstations, biological safety cabinets, and barrier isolators. The design and construction of a facility contributes to protection of both the preparation and personnel, and thus is considered a secondary engineering control. Other secondary engineering controls include cleanrooms and negative-pressure containment rooms. This article reviews primary engineering controls along with a rationale for choosing one

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2005
Pg. 284-290
Author(s): Wagner James T
Nov/Dec 2019
Pg. 447-452
Author(s): Mulder Kyle
Jan/Feb 2020
Pg. 7-12
Author(s): Mulder Kyle
Nov/Dec 2019
Pg. 511-518
Author(s): Hutson Chad, Day A J
Sep/Oct 2018
Pg. 387-398
Nov/Dec 2020
Pg. 451-458
Jul/Aug 2015
Pg. 268-278
Mar/Apr 2007
Pg. 149-151
Author(s): Allen Loyd V Jr
Mar/Apr 2006
Pg. 128-133
Author(s): Wagner James T
May/Jun 2006
Pg. 208-211
Author(s): Wagner James T
Nov/Dec 2007
Pg. 492-499
Mar/Apr 2017
Pg. 118-124
Author(s): Allen Loyd V Jr
Sep/Oct 2018
Pg. 369-384
Jan/Feb 2003
Pg. 42-43
Nov/Dec 2022
Pg. 497-504
Author(s): Summers Amy
Sep/Oct 2022
Pg. 411-418
Author(s): Summers Amy
Jul/Aug 2005
Pg. 293-298
Jul/Aug 2000
Pg. 261-263
Author(s): Lau Kellie
Jul/Aug 2020
Pg. 270-276
Nov/Dec 2013
Pg. 485-489